Image

India Hosts 19th International Conference of Drug Regulatory Authorities

The 19th ICDRA will be held in India for the first time in October 14–18, 2024. The ultimate and significant meeting, where experts come together from all across the 194 WHO member nations. The summit, in part a reflection of its leadership role during the COVID — 19 pandemic, underscores growing Indian voice in global healthcare.

India led the charge during COVID-19

  • The provision of healthcare services during the pandemic and newly generated vaccines.
  • Whatever large volumes of vaccines and medicines produced, dubbed as "Pharmacy of the World".
  • Abided by the philosophy of ‘Vasudhaiva Kutumbakam’, provided critical medical supplies to more than 150 countries.

Importance of ICDRA

  • Creates a space for experts to connect, exchange knowledge and forge partnerships on safe, effective and quality medicines.
  • Showcases India's commitment towards delivering health care in the global arena.

India's Progress with CDSCO

  • There are well laid systems for approval of drugs and medical devices in CDSCO.
  • Completed 95% of their processes in digital form to ensure transparency.
  • Specializes in low-cost, high-quality medications.

International Partnership for Improved Regulation of Drugs

  • WHO Director-General Dr Tedros Adhanom Ghebreyesus on overcoming challenges in drug regulation.

Key Topics at ICDRA

  • Strategies of Smart Regulation: Convergence in regulatory standards.
  • Medical Devices – New trends & safety standards
  • Quality of medicines: High standards for drugs.
  • Artificial Intelligence in Healthcare: Role of Artificial Intelligence for better health systems.
  • Ready the regulator: The article summarizes lessons from COVID-19 to prepare the system for future public health emergencies.

Month: 

Category: 

1